FRANKFURT: Germany’s BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.
© New Straits Times Press (M) Bhd
FRANKFURT: Germany’s BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.
© New Straits Times Press (M) Bhd